Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

Then, Ruschig developed a cell-based assay to test their effectiveness against α-LTX ... “They took this notion that it’s important to make a broadly neutralizing antibody.” However, the team was ...

Results showed seroresponse rates 21 days post vaccination (as determined by anti CHIKV human serum neutralizing antibody assay) were 97.8% (95% CI, 97.2-98.3) in the Vimkunya arm and 1.2% (95% CI ...

In their study, Reed and his colleagues demonstrated that a pre-treatment with their broadly neutralizing antibody, "MEDI8852," protected monkey test subjects from severe disease and death ...

VYD2311 is a novel monoclonal antibody (mAb) candidate being developed ... potential variability in neutralizing activity of product candidates tested in different assays, such as pseudovirus assays ...